Tonix Pharmaceuticals (TNXP) News Today $0.19 +0.03 (+18.75%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Muscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and ApnimedNovember 21 at 4:27 AM | globenewswire.comTonix Pharmaceuticals presents data, analyses of TNX-102 SL effectsNovember 18 at 11:22 PM | markets.businessinsider.comTonix Pharmaceuticals to Present at the Winter 2024 Investor Summit VirtualNovember 18 at 4:05 PM | globenewswire.comTonix Pharmaceuticals Announces Positive Data on TNX-801 Vaccine CandidateNovember 15, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)November 15, 2024 | americanbankingnews.comTonix Pharma Reveals Promising TNX-801 Vaccine DataNovember 14, 2024 | markets.businessinsider.comTonix Pharmaceuticals announces publication of study on tolerability of TNX-801November 13, 2024 | markets.businessinsider.comTonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual MeetingNovember 13, 2024 | globenewswire.comTonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company's Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised AnimalsNovember 13, 2024 | globenewswire.comTonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational HighlightsNovember 12, 2024 | markets.businessinsider.comTonix Pharma Unveils Promising TNX-1700 Cancer DataNovember 9, 2024 | markets.businessinsider.comTonix Pharma Partners for Vaccine Clinical TrialNovember 4, 2024 | markets.businessinsider.comTonix Pharmaceuticals announces research agreement with KEMRINovember 4, 2024 | markets.businessinsider.comTonix Pharmaceuticals presents data on TNX-801 at World Vaccine CongressNovember 2, 2024 | markets.businessinsider.comTonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024November 1, 2024 | globenewswire.comTonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024October 31, 2024 | theglobeandmail.comTonix Pharmaceuticals to Present at BIO-Europe® 2024October 29, 2024 | globenewswire.comTonix Pharmaceuticals to Present at the 2024 ThinkEquity ConferenceOctober 25, 2024 | globenewswire.comEmpery Asset Management LP Acquires Shares in Tonix PharmaceuticalsOctober 16, 2024 | gurufocus.comTonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)October 16, 2024 | globenewswire.comTonix Pharmaceuticals Partners with X-Chem for AI-Driven Antiviral DevelopmentOctober 11, 2024 | msn.comTonix Pharma Enhances Drug Development with AI PartnershipOctober 9, 2024 | finance.yahoo.comWhy Tonix Pharmaceuticals (TNXP) Stock Is MovingOctober 8, 2024 | benzinga.comTonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum AntiviralsOctober 8, 2024 | globenewswire.comTonix Pharmaceuticals (TNXP) Has a Promising Pipeline but Faces Financial ChallengesOctober 1, 2024 | msn.comWhat's Going On With Tonix Pharmaceuticals Stock Friday?September 27, 2024 | msn.comTonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat MigrainesSeptember 27, 2024 | globenewswire.comTonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat MigrainesSeptember 19, 2024 | globenewswire.comTonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO's Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health EmergencySeptember 16, 2024 | globenewswire.comTonix Pharmaceuticals soars after positive data on its potential mpox vaccineSeptember 9, 2024 | msn.comTNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization…September 9, 2024 | msn.comTonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeekSeptember 6, 2024 | globenewswire.comTonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)August 29, 2024 | globenewswire.comTonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox VaccineAugust 26, 2024 | msn.comTonix Collaborates With Bilthoven Biologicals To Advance Mpox Vaccine Candidate 'TNX-801'; Stock UpAugust 26, 2024 | markets.businessinsider.comTonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix’s Mpox Vaccine, TNX-801August 26, 2024 | finance.yahoo.comTonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix's Mpox Vaccine, TNX-801August 26, 2024 | globenewswire.comTonix initiates Phase II trial for emergency cocaine intoxication treatmentAugust 22, 2024 | msn.comWhat's Going On With Tonix Pharmaceuticals (TNXP) Stock?August 21, 2024 | msn.comTonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS)August 21, 2024 | finance.yahoo.comTonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine IntoxicationAugust 20, 2024 | finance.yahoo.comTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational HighlightsAugust 19, 2024 | finanznachrichten.deMpox vaccine developer Tonix surges 75% following outbreak spreadAugust 19, 2024 | msn.comTonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational HighlightsAugust 19, 2024 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Quotes, Forecast and News SummaryAugust 18, 2024 | benzinga.comTNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024August 16, 2024 | msn.comEU public health body lifts mpox risk alert level after new strain found in SwedenAugust 16, 2024 | msn.comEU public health body lifts mpox risk alert levelAugust 16, 2024 | msn.comTonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study SuggestsAugust 16, 2024 | benzinga.comTonix Pharma To Advance Development Of TNX-801 Vaccine Candidate Against Monkeypox, Stock GainsAugust 16, 2024 | markets.businessinsider.com Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. TNXP Media Mentions By Week TNXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNXP News Sentiment▼0.280.45▲Average Medical News Sentiment TNXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNXP Articles This Week▼52▲TNXP Articles Average Week Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ProPhase Labs News PowerUp Acquisition News Eupraxia Pharmaceuticals News Genelux News 23andMe News CASI Pharmaceuticals News FibroBiologics News PMV Pharmaceuticals News Oncolytics Biotech News Ikena Oncology News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNXP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNXP Stock Alerts